Company Filing History:
1 out of 2 
1 out of 1,743 
1 out of 99 
Years Active: 2017
Title: The Innovations of Christophe Magnan
Introduction
Christophe Magnan is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the treatment of insulin resistance. His innovative work has led to the development of a unique patent that addresses a critical health issue.
Latest Patents
Christophe Magnan holds a patent for a composition that includes the HIP/PAP protein or its derivatives for treating insulin resistance. This invention is particularly relevant for non-insulin dependent subjects, providing a potential solution for managing this condition effectively. The patent highlights the importance of the HIP/PAP protein in medical treatments and showcases Magnan's commitment to advancing healthcare.
Career Highlights
Throughout his career, Christophe Magnan has worked with several esteemed organizations. Notably, he has been associated with Alfact Innovation and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Christophe Magnan has collaborated with notable professionals such as Fabrizio Andreelli and Paul Amouyal. These partnerships have enriched his research and have been instrumental in the development of his innovative solutions.
Conclusion
Christophe Magnan's contributions to the field of medical research, particularly through his patent on the HIP/PAP protein, demonstrate his dedication to improving health outcomes. His work continues to inspire advancements in the treatment of insulin resistance.